Evidence map›Paper›PMID 40563548›Full record

ArticleCancers2025

Comparative Analysis of Clinical Outcomes in High-Grade Glioma Patients: 5-ALA Fluorescence-Guided Surgery vs. Conventional White-Light Resection.

Nurzhan Ryskeldiyev, Aidos Moldabekov, Dinara Berdibayeva, Aiman Maidan, Torebek Tursynbekov, Dimash Davletov, Muratbek Tleubergenov, Assel Kabykenova, Diana Kerimbayeva, Aidos Doskaliyev and 1 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Obstacles and Trials in Treating Primary Brain Tumors.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nurzhan RyskeldiyevNational Centre for Neurosurgery, Astana 010000, Kazakhstan.
Aidos MoldabekovNational Centre for Neurosurgery, Astana 010000, Kazakhstan.
Dinara BerdibayevaNational Centre for Neurosurgery, Astana 010000, Kazakhstan.
Aiman MaidanTaraz City Multidisciplinary Hospital and Consulting and Diagnostic Center, Taraz 080000, Kazakhstan.ORCID 0000-0003-3321-9714
Torebek TursynbekovNational Centre for Neurosurgery, Astana 010000, Kazakhstan.
Dimash DavletovAtchabarov Scientific-Research Institute of Fundamental and Applied Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.ORCID 0009-0006-6100-4963
Muratbek TleubergenovNational Centre for Neurosurgery, Astana 010000, Kazakhstan.
Assel KabykenovaNational Centre for Neurosurgery, Astana 010000, Kazakhstan.
Diana KerimbayevaDepartment of Psychology/Neuroscience Program, Dickinson College, Carlisle, PA 17013, USA.
Aidos DoskaliyevNational Centre for Neurosurgery, Astana 010000, Kazakhstan.
Serik AkshulakovNational Centre for Neurosurgery, Astana 010000, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background High-grade gliomas (HGGs) are aggressive brain tumors with poor prognoses. Maximizing the extent of resection (EOR) is a critical surgical goal. Fluorescence-guided surgery using 5-aminolevulinic acid (5-ALA) has been proposed to enhance tumor visualization and resection. MethodsWe retrospectively analyzed 141 patients with histologically confirmed HGGs who underwent either 5-ALA-guided (

Indexed as

5-aminolevulinic acidextent of resection (EOR)fluorescence-guided surgeryglioblastomaneuro-oncology

Identifiers

PMID40563548
PMCPMC12191055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.